Change Healthcare can notify patients about the breach, HHS says

KentNishimura/GettyImagesChangeHealthcarecannotifypatientswhosesensitivehealthinformationhasbeenexpo Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular




entertainment

author：fashion    Page View：71
The FDA building -- First Opinion coverage from STAT
Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

advertisement

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Why the Crimean Bridge is key to Russia's war in Ukraine
Next article： Medical leaders decry Supreme Court decision on affirmative action